Qian Chu

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-8192-7630

发表论文 337 篇 · 总被引 11798 次 · h-index 53

代表论文

• Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial (2025 · The Lancet · 被引 33)
• Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities (2025 · Journal of Hematology & Oncology · 被引 27)
• Breaking barriers: The cGAS‐STING pathway as a novel frontier in cancer immunotherapy (2025 · 癌症：英文版 · 被引 23)
• Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial (2025 · The Lancet Respiratory Medicine · 被引 10)
• The emerging role of microbiota in lung cancer: a new perspective on lung cancer development and treatment (2025 · Cellular Oncology · 被引 10)
• Genetic architecture of bone marrow fat fraction implies its involvement in osteoporosis risk (2025 · Nature Communications · 被引 7)